Skip to main content
Log in

Quality of life in type 2 diabetics with gastroesophageal reflux disease: a case control study

  • Original Article
  • Published:
European Surgery Aims and scope Submit manuscript

Summary

Background

To compare health- and disease-related quality of life (QoL) in patients with gastroesophageal reflux disease (GERD), with and without type 2 diabetes mellitus (T2DM).

Methods

In a retro-pro study of 29 non-diabetic and 30 diabetic GERD-patients who underwent complete esophageal testing because of GERD symptoms, three different QoL questionnaires [short-form 36 (SF-36) questionnaire, Gastrointestinal Quality of Life Index (GIQLI), GERD-health related QoL Index (GERD-HRQL)] and a standardized symptom questionnaire were analyzed.

Results

T2DM patients revealed higher body-mass-index levels (31.8 ± 6.3 vs. 28.2 ± 4.4 kg/m2, p = 0.004), whereas hiatal hernias were found less frequently in non-diabetics (82.8 vs. 32.1 %, p < 0.001). Lower esophageal sphincter pressures (LES) were higher in T2DM GERD-patients (11.1 ± 6.1 vs. 5.3 ± 4.0 mmHg; p < 0.001). In the SF-36 domains, “vitality” and “physical functioning,” T2DM patients revealed lower QoL (48.8 ± 20.3 vs. 60.0 ± 16.7, p = 0.023; and 64.7 ± 25.4 vs. 78.8 ± 19.8, p = 0.027; respectively). The GERD-HRQL (16.8 ± 13.1 vs. 18.8 ± 10.7, p > 0.05) and GIQLI (88.5 ± 25.1 vs. 94.0 ± 18.2, p  > 0.05) did not differ significantly.

Conclusions

T2DM had a major impact on health-related QoL in patients with proven GERD, with impairment of the SF-36 domains, “physical functioning” and “vitality”. GERD-specific QoL, however, was similar in diabetic and non-diabetic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Vakil N, Zanten SV van, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20.

    Article  PubMed  Google Scholar 

  2. Provenzale D. Epidemiology of gastroesophageal reflux disease. In: Orlando RC, editor. Gastroesophageal reflux disease. New York: Dekker; 2000. pp. 85–99.

  3. Gadenstätter M, Wykypiel H, Schwab GP, Profanter C, Wetscher G. Respiratory symptoms and dysphagia in patients with gastroesophageal reflux disease: A comparison of medical and surgical therapy. Langenbecks Arch Surg. 1999;38:563–7.

    Article  Google Scholar 

  4. Promberger R, Gadenstätter M, Ciovica R, Schwab G, Neumayer C. Gastroesophageal reflux disease in diabetic patients: a systematic review. Eur Surg. 2007;39:340–54.

    Article  Google Scholar 

  5. Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol. 2005;40:275–85.

    Google Scholar 

  6. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.

    Article  PubMed  Google Scholar 

  7. Virally M, Blickle JF, Girard J, Halimi S, Simon D, Guillausseau PJ. Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives. Diabetes Metab. 2007;33:231–44.

    Article  PubMed  CAS  Google Scholar 

  8. Bytzer P, Howell S, Leemon M, Young LJ, Jones MP, Talley NJ. Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults. Gut. 2001;49:66–72.

    Article  PubMed  CAS  Google Scholar 

  9. Wang X, Pitchumoni CS, Chandrarana K, Shah N. Increased prevalence of symptoms of gastroesophageal reflux diseases in type 2 diabetics with neuropathy. World J Gastroenterol. 2008;14:709–12.

    Article  PubMed  Google Scholar 

  10. Lee YC, Yen AM, Tai JJ, et al. The effect of metabolic risk factors on the natural course of gastroesophageal reflux disease. Gut. 2009;58:174–81.

    Google Scholar 

  11. Nishida T, Tsuji S, Tsujii M, et al. Gastroesophageal reflux disease related to diabetes: Analysis of 241 cases with type 2 diabetes mellitus. J Gastroenterol Hepatol. 2004;19:258–65.

    Google Scholar 

  12. Horikawa A, Ishii-Nozawa R, Ohguro M, et al. Prevalence of GORD (gastroesophageal reflux disease) in type 2 diabetes and a comparison of clinical profiles between diabetic patients with and without GORD. Diab Med. 2009;26:228–33.

    Google Scholar 

  13. Talley NJ, Wiklund I. Patient reported outcomes in gastroesophageal reflux disease: an overview of available measures. Qual Life Res. 2005;14:21–33.

    Article  PubMed  Google Scholar 

  14. Kamolz T, Pointner R. Quality of life-a factor of medical outcome in surgery. Acta Chir Austriaca. 1998;30:355–9.

    Article  Google Scholar 

  15. Kulig M, Leodolter A, Vieth M, et al. Quality of life in relation to symptoms in patients with gastroesophageal reflux disease—an analysis based on the ProGERD initiative. Aliment Pharmacol Ther. 2003;18:767–76.

    Google Scholar 

  16. Velanovich V. Quality of life and severity of symptoms in gastroesophageal reflux disease: a clinical review. Eur J Surg. 2000;166:516–25.

    Article  PubMed  CAS  Google Scholar 

  17. Ronkainen J, Aro P, Storskrubb T, et al. Gastroesophageal reflux symptoms and health related quality of life in the adult general population—the Kalixanda study. Aliment Pharmacol Ther. 2006;23:1725–33.

    Google Scholar 

  18. Kamolz T, Granderath F, Pointner R. Laparoscopic antireflux surgery: disease-related quality of life assessment before and after surgery in GERD patients with and without Barrett’s esophagus. Surg Endosc. 2003;17:880–5.

    Article  PubMed  CAS  Google Scholar 

  19. Kamolz T, Granderath FA, Schweiger UM, Pointner R. Laparoscopic Nissen fundoplication in patients with nonerosive reflux disease. Long-term quality-of-life assessment and surgical outcome. Surg Endosc. 2005;19:494–500.

    Article  PubMed  CAS  Google Scholar 

  20. Schunk M, Reitmeir P, Schipf S, et al. Health-related quality of life in subjects with and without Type 2 diabetes: pooled analysis of five population-based surveys in Germany. Diabetes Med. 2012;29:646–53.

    Google Scholar 

  21. Sikdar KC, Wang PP, MacDonald D, Gadag VG. Diabetes and its impact on health related quality of life: a life table analysis. Qual Life Res. 2010;19:781–7.

    Article  PubMed  Google Scholar 

  22. Clouet F, Excler-Cavailher G, Christophe B, Masson F, Fasquel D. Type 2 diabetes and short-form 36-items Health Survey. Diabetes Metab. 2001;27:711–7.

    PubMed  CAS  Google Scholar 

  23. Chittleborough CR, Baldock KL, Taylor AW, Phillips PJ. Health status assessed by the SF-36 along the diabetes continuum in an Australian population. Qual Life Res. 2006;15:687–94.

    Article  PubMed  Google Scholar 

  24. Talley NJ, Young L, Bytzer P, et al. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol. 2001;96:71–6.

    Google Scholar 

  25. Hall JC, Hall JL. Emergence of †retropro’ studies in the surgical literature. ANZ J Surg. 2008;78:411–3.

    Article  PubMed  Google Scholar 

  26. American Diabetes Association. Standards of medical care in diabetes—2006. Diabetes Care. 2006;29:S4–42.

    Google Scholar 

  27. Ciovica R, Gadenstätter M, Klingler A, Lechner W, Riedl O, Schwab GP. Quality of life in GERD patients: medical treatment versus antireflux surgery. J Gastrointest Surg. 2006;10:934–9.

    Google Scholar 

  28. Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. BJS. 1995;82:216–22.

    Google Scholar 

  29. Velanovich V, Vallance SR. Gusz JR, Tapia FV, Harkabus MA. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg. 1996;183:217–24.

    PubMed  CAS  Google Scholar 

  30. Bullinger M, Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Handanweisung. Göttingen:Hogrefe-Verlag; 1998.

  31. Ollyo JB, Fontolliet C, Lang BF. La nouvelle classification de Savary des oesophagites de reflux. Acta Endoscopica. 1992;22:307–20.

    Article  Google Scholar 

  32. Riddell RH. The biopsy diagnosis of gastroesophageal reflux disease, “carditis’’, and Barrett’s esophagus and sequelae of therapy. Am J Surg Pathol. 1996;20:S31–50.

    Article  PubMed  Google Scholar 

  33. Zaninotto G, DeMeester TR, Schwizer W, Johansson KE, Cheng SC. The lower esophageal sphincter in health and disease. Am J Surg. 1988;155:104–11.

    Article  PubMed  CAS  Google Scholar 

  34. DeMeester TR, Wang CI, Wernly JA, et al. Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thor Cardiovasc Surg. 1980;79:656–70.

    Google Scholar 

  35. Hershcovici T, Jha LK, Gadam R, et al. The relationship between type 2 diabetes mellitus and failure to proton pump inhibitor treatment in gastroesophageal reflux disease. J Clin Gastroenterol. 2012;46:662–8.

    Google Scholar 

  36. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4–14.

    Article  PubMed  CAS  Google Scholar 

  37. Festi D, Scaioli E, Baldi F, et al. Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. World J Gastroenterol. 2009;15:1690–701.

    Google Scholar 

  38. El-Serag H. Role of obesity in GORD-related disorders. Gut. 2008;57:281–4.

    Article  PubMed  Google Scholar 

  39. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterol. 2005;129:1825–31.

    Google Scholar 

  40. Wex T, Mönkemüller K, Stahr A, et al. Gastroesophageal reflux disease is associated with up-regulation of desmosomal components in esophageal mucosa. Histopathol. 2012;60:405–15.

    Google Scholar 

  41. Kandulski A, Wex T, Mönkemüller K, et al. Proteinase-activated receptor-2 in the pathogenesis of gastroesophageal reflux disease. Am J Gastroenterol. 2010;105:1934–43.

    Google Scholar 

  42. Choi CW, Kim GH, Song CS, et al. Is obesity associated with gastropharyngeal reflux disease? World J Gastroenterol. 2008;14:265–71.

    Google Scholar 

  43. Neumayer C, Ciovica R, Gadenstätter M, et al. Significant weight loss after laparoscopic Nissen fundoplication. Surg Endosc. 2005;19:15–20.

    Google Scholar 

  44. Norris SL, McNally TK, Zhang X, et al. Published norms under estimate the health-related quality of life among persons with type 2 diabetes. J Clin Epidemiol. 2011;64:358–65.

    Google Scholar 

  45. Alonso J, Ferrer M, Gandek B, et al. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res. 2004;13:283–98.

    Google Scholar 

  46. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev. 1999;15:205–18.

    Article  PubMed  CAS  Google Scholar 

  47. Luyster FS, Dunbar-Jacob J. Sleep quality and quality of life in adults with type 2 diabetes. Diabetes Educ. 2011;37:347–55.

    Article  PubMed  Google Scholar 

  48. Mezuk B, Eaton W, Albrecht S, Hill Golden S. Depression and type 2 diabetes over the life span. A meta-analysis. Diabetes Care. 2008;31:2383–90.

    Article  PubMed  Google Scholar 

  49. Kinekawa F, Kubo F, Matsuda K, et al. Esophageal function worsens with long duration of diabetes. J Gastroenterol. 2008;43:338–44.

    Google Scholar 

  50. Velanovich V, Karmy-Jones R. Measuring gastroesophageal reflux disease: relationship between the Health-Related Quality of Life score and physiologic parameters. The American Surgeon. 1998;64:649–53.

    PubMed  CAS  Google Scholar 

  51. Iyer PG, Borah BJ, Heien HC, et al. Association of Barrett’s esophagus with type II diabetes mellitus: results from a Large Population-Based Case Control Study. Clin Gastroenterol Hepatol. 2013. doi:10.1016/j.cgh.2013.03.024.

Download references

Conflict of interest

The authors declare that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Promberger, R., Spitzer, A., Ott, J. et al. Quality of life in type 2 diabetics with gastroesophageal reflux disease: a case control study. Eur Surg 45, 194–199 (2013). https://doi.org/10.1007/s10353-013-0219-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10353-013-0219-7

Keywords

Navigation